BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 38687347)

  • 1. Waldenström macroglobulinemia: a review of the entity and its differential diagnosis.
    Shaheen SP; Talwalkar SS; Lin P; Medeiros LJ
    Adv Anat Pathol; 2012 Jan; 19(1):11-27. PubMed ID: 22156831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA aberrations in Waldenström macroglobulinemia.
    Sacco A; Zhang Y; Maiso P; Manier S; Rossi G; Treon SP; Ghobrial IM; Roccaro AM
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):205-7. PubMed ID: 23474146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience.
    Danesin N; Bonaldi L; Martines A; Nalio S; Bertorelle R; Compagno S; Marcato R; Manni S; Scarmozzino F; Pizzi M; Tos APD; Cellini A; Scapinello G; Visentin A; Trentin L; Piazza F
    Ann Hematol; 2024 Apr; ():. PubMed ID: 38687347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: Correlations and prognostic impact.
    Krzisch D; Guedes N; Boccon-Gibod C; Baron M; Bravetti C; Davi F; Armand M; Smagghe L; Caron J; Bernard OA; Susin S; Chapiro E; Leblond V; Nguyen-Khac F; Roos-Weil D;
    Am J Hematol; 2021 Dec; 96(12):1569-1579. PubMed ID: 34462944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic findings in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia. Chromosomal abnormalities are associated with the polymorphous subtype and an aggressive clinical course.
    Mansoor A; Medeiros LJ; Weber DM; Alexanian R; Hayes K; Jones D; Lai R; Glassman A; Bueso-Ramos CE
    Am J Clin Pathol; 2001 Oct; 116(4):543-9. PubMed ID: 11601139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Waldenström macroglobulinemia: Japanese perception].
    Sekiguchi N
    Rinsho Ketsueki; 2019; 60(8):988-997. PubMed ID: 31484900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis.
    Ocio EM; Schop RF; Gonzalez B; Van Wier SA; Hernandez-Rivas JM; Gutierrez NC; Garcia-Sanz R; Moro MJ; Aguilera C; Hernandez J; Xu R; Greipp PR; Dispenzieri A; Jalal SM; Lacy MQ; Gonzalez-Paz N; Gertz MA; San Miguel JF; Fonseca R
    Br J Haematol; 2007 Jan; 136(1):80-6. PubMed ID: 17222197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunophenotypic and cytogenetic comparison of Waldenstrom's macroglobulinemia with splenic marginal zone lymphoma.
    Ocio EM; Hernandez JM; Mateo G; Sanchez ML; Gonzalez B; Vidriales B; Gutierrez NC; Orfao A; San Miguel JF
    Clin Lymphoma; 2005 Mar; 5(4):241-5. PubMed ID: 15794856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline.
    Walewska R; Eyre TA; Barrington S; Brady J; Fields P; Iyengar S; Joshi A; Menne T; Parry-Jones N; Walter H; Wotherspoon A; Linton K;
    Br J Haematol; 2024 Jan; 204(1):86-107. PubMed ID: 37957111
    [No Abstract]   [Full Text] [Related]  

  • 10. New developments in the diagnosis and characterization of Waldenström's macroglobulinemia.
    García-Sanz R; Hunter ZR; Poulain S; Varettoni M; Owen RG
    Expert Rev Hematol; 2023; 16(11):835-847. PubMed ID: 37905549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital.
    Danesin N; Lo Schirico M; Scapinello G; Grassi A; Riva M; Berno T; Branca A; Visentin A; Carraro M; Pavan L; Manni S; Bonaldi L; Martines A; Bertorelle R; Vianello F; Gurrieri C; Briani C; Zambello R; Trentin L; Piazza F
    Hemasphere; 2023 Oct; 7(10):e964. PubMed ID: 37799344
    [No Abstract]   [Full Text] [Related]  

  • 12. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia.
    Garcia-Sanz R; Varettoni M; Jiménez C; Ferrero S; Poulain S; San-Miguel JF; Guerrera ML; Drandi D; Bagratuni T; McMaster M; Roccaro AM; Roos-Weil D; Leiba M; Li Y; Qiu L; Hou J; De Larrea CF; Castillo JJ; Dimopoulos M; Owen RG; Treon SP; Hunter ZR
    Semin Hematol; 2023 Mar; 60(2):90-96. PubMed ID: 37099028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report of consensus panel 1 from the 11
    Buske C; Castillo JJ; Abeykoon JP; Advani R; Arulogun SO; Branagan AR; Cao X; D'Sa S; Hou J; Kapoor P; Kastritis E; Kersten MJ; LeBlond V; Leiba M; Matous JV; Paludo J; Qiu L; Tam CS; Tedeschi A; Thomas SK; Tohidi-Esfahani I; Varettoni M; Vos JM; Garcia-Sanz R; San-Miguel J; Dimopoulos MA; Treon SP; Trotman J
    Semin Hematol; 2023 Mar; 60(2):73-79. PubMed ID: 37099027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic aberrations of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia in Chinese patients.
    Xiong W; Wang T; Yu Y; Jiao Y; Chen J; Wang Y; Li C; Lyu R; Wang Q; Liu W; Sui W; An G; Zou D; Qiu L; Yi S
    Chin Med J (Engl); 2023 May; 136(10):1240-1242. PubMed ID: 37057735
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.
    Dogliotti I; Jiménez C; Varettoni M; Talaulikar D; Bagratuni T; Ferrante M; Pérez J; Drandi D; Puig N; Gilestro M; García-Álvarez M; Owen R; Jurczak W; Tedeschi A; Leblond V; Kastritis E; Kersten MJ; D'Sa S; Kaščák M; Willenbacher W; Roccaro AM; Poulain S; Morel P; Kyriakou C; Fend F; Vos JMI; Dimopoulos MA; Buske C; Ferrero S; García-Sanz R
    Leukemia; 2023 Feb; 37(2):388-395. PubMed ID: 36435884
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.